What scleral‑show percentage of the corneal diameter is considered indicative of true exophthalmos?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Scleral Show Percentage for Exophthalmos

True exophthalmos is defined by exophthalmometer measurements exceeding 19 mm, not by a specific percentage of scleral show relative to corneal diameter. 1

Diagnostic Criteria for Exophthalmos

The gold standard for diagnosing exophthalmos relies on exophthalmometer measurements rather than scleral show percentages:

  • Normal range: 10.5-18.8 mm (95% confidence limits in individuals without thyroid disease) 1
  • Exophthalmos threshold: ≥19 mm on exophthalmometer measurement 1
  • Prevalence: 21.3% of thyrotoxic patients demonstrate exophthalmos by this criterion 1

Key Clinical Distinction

The question conflates two separate anatomical findings:

  • Exophthalmos = anterior displacement of the globe due to increased orbital contents in a normal bony orbit 2
  • Scleral show = visible sclera exposure (typically inferior) that can occur independently of true exophthalmos 3

Scleral Show Assessment

While no specific percentage of corneal diameter defines exophthalmos, excessive inferior scleral show is assessed qualitatively rather than quantitatively:

  • Scleral show represents an anatomical condition where sclera area is visibly exaggerated 3
  • It can occur from constitutional, endocrine, or iatrogenic causes without true exophthalmos 3
  • In long-face patients with excess scleral show, surgical correction achieved 8% and 6% decreases in scleral show relative to total eye height (right and left eyes respectively) 4

Clinical Pitfall

Do not diagnose exophthalmos based solely on scleral show appearance. Scleral show is not always linked to globe protrusion and requires differentiation from true exophthalmos through exophthalmometry 3. The mechanisms of globe protrusion must be distinguished before planning any orbital intervention 2.

Imaging Confirmation

When exophthalmos is suspected clinically:

  • MRI of the orbits with and without contrast is the optimal imaging modality to localize and characterize orbital pathology causing proptosis 5
  • CT imaging with multiplanar reconstructions identifies osseous orbital abnormalities 5
  • Computed tomography measurements can differentiate exophthalmos (increased orbital contents) from exorbitism (decreased orbital capacity) 2

Bilateral vs Unilateral Presentation

Exophthalmos is bilateral in 85-90% of cases, particularly in thyroid eye disease 6. Unilateral or asymmetric proptosis raises concern for underlying mass lesions, vascular malformations, or carotid-cavernous fistula 5.

References

Research

Orbital morphology in exophthalmos and exorbitism.

Plastic and reconstructive surgery, 2006

Research

Scleral show.

Aesthetic plastic surgery, 1988

Research

Individuals With a Long Face Growth Pattern and Excess Inferior Scleral Exposure: Is There Improvement After Maxillary (Le Fort I) Advancement and Vertical Shortening?

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Basedow exophthalmos].

Journal francais d'ophtalmologie, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.